about
Pharmacogenomics and drug response in cardiovascular disorders[Cost] effectiveness of withdrawal of fall-risk increasing drugs versus conservative treatment in older fallers: design of a multicenter randomized controlled trial (IMPROveFALL-study).Understanding and preventing drug-drug and drug-gene interactions.Is hormonal treatment still an option in acne today?Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations.Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality.Drug interactions in the management of HIV infection.Pharmacotherapy of onychomycosis.Current use of anti-infectives in dermatology.Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment.Functional evolution of the pregnane X receptor.Drug interactions in the management of HIV infection: an update.Clinically based evidence of drug-herb interactions: a systematic review.Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis.Viekira Pak Induced Fatal Lactic Acidosis: A Case Report of an Unusual Side EffectReview and Management of Acneiform Eruptions in Patients with Immune Disorders.Skin and Psyche : Diversionary Symbiosis.Drug interactions in dermatology: what the dermatologist should know.Potential elevation of tacrolimus trough concentrations with concomitant metronidazole therapy.
P2860
Q28171051-C5F6749E-301A-49CD-9A54-17842F360CB2Q33997908-DE6877CD-AB69-4584-B79D-5473E14A2518Q34415944-15D6F3F4-2583-4CB5-B299-AEC83BA00832Q34667697-F6A7015F-0F67-4F96-9CB4-0B58E538DB18Q35023711-B07AC051-14E5-490B-9725-BE386FF8BAE6Q35166739-CF52ED25-97BF-425F-8FCD-B9E4EBB9425AQ36066083-76C85881-9642-4AC6-8628-371F86B153E6Q36150713-1048B9D5-1DE8-42FE-BEE4-255E1C277248Q36233506-7C5F58C0-C934-407B-826A-277713B9E2D6Q36412047-D0EE2686-3948-458C-88CC-7184A698AD4AQ36440155-C100EBEA-9A10-4174-91EB-7EBB38090466Q37000733-CDF4CD1D-2429-40C3-B343-462D2F7B5236Q37658866-F93CC764-68F0-4930-99A8-6F0A50229265Q38962747-78646655-0A70-4D3C-97E2-31EDAB55EA82Q39043731-1CD0B001-6A6D-4E4B-8C0B-16840767D1BDQ39155649-FAFE6950-BB9D-409A-8879-BD924FCD92E8Q42532713-975C1BF8-9636-4B07-994E-D27EB35002D4Q43069216-8DAE7E96-6EF7-485A-83D6-298DC31ED5ABQ46458612-D58BDB4D-FDAF-458D-8CFC-937AF783F922
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Drug interactions: Proteins, pumps, and P-450s.
@ast
Drug interactions: Proteins, pumps, and P-450s.
@en
Drug interactions: Proteins, pumps, and P-450s.
@nl
type
label
Drug interactions: Proteins, pumps, and P-450s.
@ast
Drug interactions: Proteins, pumps, and P-450s.
@en
Drug interactions: Proteins, pumps, and P-450s.
@nl
prefLabel
Drug interactions: Proteins, pumps, and P-450s.
@ast
Drug interactions: Proteins, pumps, and P-450s.
@en
Drug interactions: Proteins, pumps, and P-450s.
@nl
P356
P1476
Drug interactions: Proteins, pumps, and P-450s.
@en
P2093
Lori E Shapiro
Neil H Shear
P304
467-84; quiz 485-8
P356
10.1067/MJD.2002.126823
P407
P577
2002-10-01T00:00:00Z